BioXcel Therapeutics Cash Flow Statement (2022-2025) | BTAI

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -31.47M-37.67M-41.87M-53.47M-52.22M-54.05M-50.48M-20.99M-26.82M-20.32M-18.47M-14.40M-13.46M-19.45M-18.36M-13.89M
Depreciation and Depletion (Quarter) 0.08M0.08M0.09M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.07M0.07M0.07M
Share-based Compensation (Quarter) 3.83M4.48M4.48M4.55M4.88M6.12M4.01M3.60M3.43M1.06M1.86M-0.20M0.18M1.10M0.58M0.45M
Gains from Sales and Divestitures (Quarter) 0.03M0.06M0.06M0.07M0.01M0.01M5.000.01M
Gains from Investment Securities (Quarter) 0.12M0.12M-0.34M0.02M30.0030.000.23M0.01M4.83M0.63M0.05M0.00M0.07M
Non-cash Items (Quarter) 2.84M21.44M18.07M15.48M3.11M3.21M19.56M3.48M3.66M3.89M0.25M0.25M0.26M0.68M0.33M
Cash from Operations (Quarter) -32.41M-33.10M-31.19M-38.64M-52.35M-38.21M-37.58M-26.86M-17.71M-23.17M-16.34M-14.81M-12.04M-12.57M-18.79M-14.21M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.07M0.07M0.07M0.07M0.07M0.07M0.08M0.08M0.08M0.08M0.08M0.08M
Amortization of Deferred Charges (Quarter) 0.32M0.22M0.46M0.33M0.36M0.38M0.16M0.04M0.10M0.11M0.22M2.67M0.39M0.44M-3.78M
Depreciation & Amortization (CF) (Quarter) 0.08M0.08M0.09M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.07M0.07M0.07M
Change in Working Capital
Change in Receivables (Quarter) 0.04M0.15M0.30M-0.66M0.31M0.43M-0.81M0.13M-0.13M0.02M-0.02M0.23M
Change in Inventory (Quarter) 0.68M0.71M0.01M0.58M-0.03M-0.03M0.09M-0.03M0.45M0.24M-1.16M-0.85M-0.04M-0.14M-0.05M0.26M
Change in Accured Expenses (Quarter) -0.68M3.99M-0.42M0.91M1.19M1.04M-1.08M-4.37M4.83M-5.48M-0.08M-2.27M2.27M-1.04M8.01M
Investing Activities
Capital Expenditures (Quarter) 0.12M0.02M
Cash from Investing Activities (Quarter) -0.12M-0.02M
Financing Activities
Other financing activities (Quarter) 0.74M0.07M0.12M0.16M0.01M0.18M0.80M0.14M0.34M0.12M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 30.00M
Change in Capital Stock
Shares Issued (Quarter) 0.05M0.05M0.26M24.40M-24.15M26.74M5.31M0.47M7.00M14.01M0.14M38.23M5.76M
Misc.
Cash from Financing Activities (Quarter) 30.05M0.05M24.15M0.25M2.12M26.63M5.30M0.45M4.28M13.20M0.14M37.53M5.65M
Change in Cash (Quarter) -32.53M33.02M-1.14M-38.59M-28.20M-37.98M-37.58M-24.74M8.92M-17.87M-15.88M-10.53M1.16M-12.44M18.75M-8.56M
Free Cash Flow (Quarter) -32.53M-33.12M-31.19M-38.64M-52.35M-38.21M-37.58M-26.86M-17.71M-23.17M-16.34M-14.81M-12.04M-12.57M-18.79M-14.21M
Net Cash Flow (Quarter) -32.53M-33.12M-1.14M-38.59M-28.20M-37.96M-37.58M-24.74M8.92M-17.87M-15.88M-10.53M1.16M-12.44M18.75M-8.56M